Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis (Q37105146)

18 August 2017

14 references

12 March 2019

13 March 2019

21 March 2019

3 April 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

1 August 2019

3 October 2019

20 November 2019

27 November 2019

1 February 2021

28 October 2022

Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis (English)

1 reference

18 August 2017

0 references

0 references

12 references

12 March 2019

13 March 2019

21 March 2019

3 April 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

1 August 2019

3 October 2019

20 November 2019

27 November 2019

12 references

12 March 2019

13 March 2019

21 March 2019

3 April 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

1 August 2019

3 October 2019

20 November 2019

27 November 2019

13 references

12 March 2019

13 March 2019

21 March 2019

3 April 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

1 August 2019

3 October 2019

20 November 2019

27 November 2019

28 October 2022

Tumor necrosis factor

2 references

1 August 2019

1 February 2021

1 reference

20 November 2019

1 reference

27 November 2019

Daniel Sánchez-Cano

1

0 references

Norberto Ortego-Centeno

object named as

Norberto Ortego-Centeno

5

0 references

Ricardo Ruiz Villaverde

object named as

Ricardo Ruiz-Villaverde

3

0 references

Raquel Ríos-Férnandez

1 reference

ORCID Public Data File 2021

author name string

José Luis Callejas-Rubio

2

1 reference

PMCID

3747407

18 August 2017

Raquel Ríos-Fernández

4

1 reference

PMCID

3747407

18 August 2017

language of work or name

1 reference

1 August 2013

15 references

Mediators of Inflammation

18 August 2017

12 March 2019

13 March 2019

21 March 2019

3 April 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

1 August 2019

3 October 2019

20 November 2019

27 November 2019

1 February 2021

28 October 2022

15 references

18 August 2017

12 March 2019

13 March 2019

21 March 2019

3 April 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

1 August 2019

3 October 2019

20 November 2019

27 November 2019

1 February 2021

28 October 2022

2013

1 reference

18 August 2017

286857

1 reference

Creative Commons Attribution 3.0 Unported

18 August 2017

14 references

12 March 2019

13 March 2019

21 March 2019

3 April 2019

22 April 2019

25 April 2019

17 June 2019

25 June 2019

1 August 2019

3 October 2019

20 November 2019

27 November 2019

1 February 2021

on focus list of Wikimedia project

28 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Management of ocular sarcoidosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab for the treatment of Behçet's disease: experience in 19 patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Long-term treatment with infliximab in patients with sarcoidosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Disfiguring annular sarcoidosis improved by adalimumab

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Medically refractory neurosarcoidosis treated with infliximab

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Osseous sarcoidosis treated with tumor necrosis factor-inhibitors: case report and review of the literature

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

TNF-α antagonists beyond approved indications: stories of success and prospects for the future.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis

14 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

14 September 2017

12 December 2020

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

The treatment of lupus pernio: results of 116 treatment courses in 54 patients.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

EULAR recommendations for the management of Behçet disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Biological response modifier therapy for refractory childhood uveitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Biologic therapeutics in the treatment of psoriasis. Part 1: review

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Inflammatory bowel disease: clinical aspects and established and evolving therapies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Off-label uses of biologic agents in dermatology: a 2006 update

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab in the therapy of uveitis in childhood

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab for sight-threatening uveitis in Behçet's disease.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Biological therapies of autoimmune diseases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Ocular inflammatory effects of intravitreally-injected tumor necrosis factor

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Infliximab treatment of Familial Mediterranean fever and its effect on secondary AA amyloidosis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

A three-centre experience with adalimumab for the treatment of non-infectious uveitis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behçet's disease responding to infliximab

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Effect of infliximab in progressive neuro-Behçet's syndrome

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Neurosarcoidosis presenting as a cerebellar mass

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab: a new modality for Behçet's disease?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab for juvenile idiopathic arthritis-associated uveitis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Use of adalimumab in refractory non-infectious childhood chronic uveitis: efficacy in ocular disease--a case cohort interventional study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Head and neck sarcoidosis, from wait and see to tumor necrosis factor alpha therapy: a pilot study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Safety and efficacy of etanercept in children with juvenile-onset Behcets disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Treatment of refractory neurosarcoidosis with Infliximab.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Safety and efficacy of infliximab therapy in active behcet's uveitis: an open-label trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

A case of panuveitis with optic disc neovascularization associated with juvenile idiopathic arthritis which progressed during a clinical trial of etanercept

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Effectiveness of infliximab in treating selected patients with sarcoidosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747407

Pulmonary Sarcoidosis following Etanercept Treatment

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2013%2F286857

Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2013%2F286857

Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge

21 January 2018

1 reference

12 December 2020

Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy

1 reference

12 December 2020

Optic neuropathy in refractory neurosarcoidosis treated with TNF-alpha antagonist

1 reference

12 December 2020

Adalimumab therapy for refractory uveitis: a pilot study

1 reference

12 December 2020

Relevance of 99mTc-HYNIC-tir-octreotide scintigraphy in a patient affected by sarcoidosis with lung and joints involvement and secondary Sjogren's syndrome treated with infliximab: case report

1 reference

12 December 2020

Successful treatment of resistant Behçet's disease with etanercept

1 reference

12 December 2020

Biologic response modifier therapy for psoriatic ocular inflammatory disease

1 reference

12 December 2020

Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept

1 reference

12 December 2020

Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis

1 reference

12 December 2020

Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial

1 reference

12 December 2020

Treatment of recurrent Crohn's uveitis with infliximab

1 reference

12 December 2020

[Successful treatment of cystoid macular edema with etanercept in a patient with rheumatoid arthritis associated panuveitis]

1 reference

12 December 2020

Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis

1 reference

12 December 2020

Adalimumab therapy for childhood uveitis

1 reference

12 December 2020

Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab

1 reference

12 December 2020

Favorable response to high-dose infliximab for refractory childhood uveitis

1 reference

12 December 2020

Radiographic improvement in sarcoid arthropathy after infliximab treatment

1 reference

12 December 2020

Do tumor necrosis factor inhibitors cause uveitis? A registry-based study

1 reference

12 December 2020

Cardiac sarcoidosis responding to monotherapy with infliximab

1 reference

12 December 2020

Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis

1 reference

12 December 2020

Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects

1 reference

12 December 2020

The development of sarcoidosis on antitumour necrosis factor therapy: a paradox

1 reference

12 December 2020

Acute sarcoidosis as parotid fever in rheumatoid arthritis under anti-tumor necrosis factor-alpha therapy

1 reference

12 December 2020

New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases

1 reference

12 December 2020

Tumor necrosis factor-alpha antagonist-induced sarcoidosis

1 reference

12 December 2020

Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab

1 reference

12 December 2020

Refractory vertebral sarcoidosis responding to infliximab

1 reference

12 December 2020

Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients

1 reference

12 December 2020

Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study

1 reference

12 December 2020

Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFalpha treatment

1 reference

12 December 2020

Beneficial effect of infliximab on refractory sarcoidosis

1 reference

12 December 2020

Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis

1 reference

12 December 2020

Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors

1 reference

12 December 2020

Efficacy of etanercept in the treatment of a patient with Behçet's disease

1 reference

12 December 2020

[Efficacy of adalimumab in Behçet's disease. Description of 6 cases]

1 reference

12 December 2020

Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment

1 reference

12 December 2020

Refractory neurosarcoidosis responsive to infliximab

1 reference

12 December 2020

Successful treatment of cardiac sarcoidosis with infliximab

1 reference

12 December 2020

Facial granulomatous nodules during etanercept treatment for psoriasis

1 reference

12 December 2020

Tumour necrosis factor-induced uveitis in the Lewis rat is associated with intraocular interleukin 6 production

1 reference

12 December 2020

Retrospective analysis of children with uveitis treated with infliximab

1 reference

12 December 2020

Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/286857

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

3747407